by Mohamad A. Mikati M.D., is the Wilburt C. Davison Professor of Pediatrics, Professor of Neurobiology, and Chief of the Division of Pediatric Neurology. Dr. Mikati´s clinical research has centred on characterisation genetics and therapy of pediatric epilepsy and Alternating Hemiplegia of Childhood.
In the laboratory he has elucidated mechanisms of seizure related neuronal injury, particularly those related to the ceramide pathway, demonstrated neuroprotective effects of several agents including erythropoietin and most recently he has concentrated his laboratory research on the pathophysiology of ATP1A3 dysfunction in animal models of Alternating Hemiplegia of Childhood with the eventual goal of hopefully identifying novel therapies for that disorder.
Recent Comments